BACKGROUND: Metabolic alterations and abnormalities of fat distribution are common findings in antiretroviral-treated HIV-1-infected patients. CD36 is a multifunctional receptor with a wide tissue distribution that plays a crucial role in the cellular uptake and metabolism of lipids. OBJECTIVES: To define the level of CD36 expression on circulating monocytes from HIV-1-infected patients and healthy controls (HCs) and to correlate CD36 expression levels with metabolic and immunovirologic parameters. METHODS: CD36 expression on peripheral blood monocytes was measured by means of flow cytometry in 165 HIV-1-infected patients and in 35 HCs. Statistical analysis was performed by means of univariate and multivariate analysis of variance models. RESULTS: CD36 expression was significantly higher in HIV-1-infected patients compared with HCs (P < 0.0001). HIV-1 infection was the only variable associated with CD36 expression on multivariate analysis, whereas no correlation was found between CD36 level and age, sex, body mass index, lipid serum levels, HIV RNA levels, time on antiretroviral therapy, or kind of antiretroviral regimen. CONCLUSIONS: HIV-1 infection is associated with increased expression of CD36 on circulating monocytes, and antiretroviral drugs play only a minor role in the complex homeostasis of this receptor. Given its role in the cellular uptake and accumulation of lipids, CD36 increased levels on monocytes could represent a proatherogenic condition in HIV-infected patients.
BACKGROUND: Metabolic alterations and abnormalities of fat distribution are common findings in antiretroviral-treated HIV-1-infectedpatients. CD36 is a multifunctional receptor with a wide tissue distribution that plays a crucial role in the cellular uptake and metabolism of lipids. OBJECTIVES: To define the level of CD36 expression on circulating monocytes from HIV-1-infectedpatients and healthy controls (HCs) and to correlate CD36 expression levels with metabolic and immunovirologic parameters. METHODS:CD36 expression on peripheral blood monocytes was measured by means of flow cytometry in 165 HIV-1-infectedpatients and in 35 HCs. Statistical analysis was performed by means of univariate and multivariate analysis of variance models. RESULTS:CD36 expression was significantly higher in HIV-1-infectedpatients compared with HCs (P < 0.0001). HIV-1 infection was the only variable associated with CD36 expression on multivariate analysis, whereas no correlation was found between CD36 level and age, sex, body mass index, lipid serum levels, HIV RNA levels, time on antiretroviral therapy, or kind of antiretroviral regimen. CONCLUSIONS:HIV-1 infection is associated with increased expression of CD36 on circulating monocytes, and antiretroviral drugs play only a minor role in the complex homeostasis of this receptor. Given its role in the cellular uptake and accumulation of lipids, CD36 increased levels on monocytes could represent a proatherogenic condition in HIV-infectedpatients.
Authors: Maria Letizia Giardino Torchia; Elena Ciaglia; Anna Maria Masci; Laura Vitiello; Manuela Fogli; Andrea la Sala; Domenico Mavilio; Luigi Racioppi Journal: PLoS One Date: 2010-06-10 Impact factor: 3.240
Authors: Antoinette C van der Kuyl; Remco van den Burg; Fokla Zorgdrager; Fedde Groot; Ben Berkhout; Marion Cornelissen Journal: PLoS One Date: 2007-02-28 Impact factor: 3.240
Authors: Lauren H Nagy; Irina Grishina; Monica Macal; Lauren A Hirao; William K Hu; Sumathi Sankaran-Walters; Christopher A Gaulke; Richard Pollard; Jennifer Brown; Maria Suni; Andreas J Baumler; Smita Ghanekar; Maria L Marco; Satya Dandekar Journal: PLoS One Date: 2013-08-30 Impact factor: 3.240
Authors: Flávio Lemos Matassoli; Ihid Carneiro Leão; Bruno Braz Bezerra; Richard B Pollard; Dieter Lütjohann; James E K Hildreth; Luciana Barros de Arruda Journal: mSphere Date: 2018-11-07 Impact factor: 4.389
Authors: Jing Qin Wu; Wayne B Dyer; Jeremy Chrisp; Larissa Belov; Bin Wang; Nitin K Saksena Journal: Retrovirology Date: 2008-03-04 Impact factor: 4.602